vs
Amarin Corp plc（AMRN）与INTEST CORP（INTT）财务数据对比。点击上方公司名可切换其他公司
Amarin Corp plc的季度营收约是INTEST CORP的1.4倍（$45.1M vs $32.8M），INTEST CORP净利率更高（3.8% vs -23.3%，领先27.1%），Amarin Corp plc同比增速更快（7.0% vs -10.3%），过去两年INTEST CORP的营收复合增速更高（4.9% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
INTEST CORP是面向全球半导体产业的专业测试设备供应商，主营研发、生产及销售热管理系统、测试接口硬件、晶圆处理工具等产品，客户覆盖晶圆制造厂、芯片设计企业及汽车、工业电子等下游领域。
AMRN vs INTT — 直观对比
营收规模更大
AMRN
是对方的1.4倍
$32.8M
营收增速更快
AMRN
高出17.3%
-10.3%
净利率更高
INTT
高出27.1%
-23.3%
两年增速更快
INTT
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $32.8M |
| 净利润 | $-10.5M | $1.2M |
| 毛利率 | — | 45.4% |
| 营业利润率 | 35.5% | 3.9% |
| 净利率 | -23.3% | 3.8% |
| 营收同比 | 7.0% | -10.3% |
| 净利润同比 | 33.0% | -17.4% |
| 每股收益（稀释后） | — | $0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNINTT
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $32.8M | ||
| Q3 25 | $49.7M | $26.2M | ||
| Q2 25 | $72.7M | $28.1M | ||
| Q1 25 | $42.0M | $26.6M | ||
| Q4 24 | $62.3M | $36.6M | ||
| Q3 24 | $42.3M | $30.3M | ||
| Q2 24 | $67.5M | $34.0M |
净利润AMRNINTT
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $1.2M | ||
| Q3 25 | $-7.7M | $-938.0K | ||
| Q2 25 | $-14.1M | $-503.0K | ||
| Q1 25 | $-15.7M | $-2.3M | ||
| Q4 24 | $-48.6M | $1.5M | ||
| Q3 24 | $-25.1M | $495.0K | ||
| Q2 24 | $1.5M | $230.0K |
毛利率AMRNINTT
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | 45.4% | ||
| Q3 25 | 44.7% | 41.9% | ||
| Q2 25 | 69.2% | 42.6% | ||
| Q1 25 | 59.8% | 41.5% | ||
| Q4 24 | -15.4% | 39.7% | ||
| Q3 24 | 38.5% | 46.3% | ||
| Q2 24 | 63.4% | 40.6% |
营业利润率AMRNINTT
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 3.9% | ||
| Q3 25 | -22.4% | -4.5% | ||
| Q2 25 | -22.0% | -3.3% | ||
| Q1 25 | -39.9% | -10.8% | ||
| Q4 24 | -84.3% | 5.7% | ||
| Q3 24 | -59.5% | 1.6% | ||
| Q2 24 | -0.8% | 1.0% |
净利率AMRNINTT
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | 3.8% | ||
| Q3 25 | -15.6% | -3.6% | ||
| Q2 25 | -19.4% | -1.8% | ||
| Q1 25 | -37.4% | -8.7% | ||
| Q4 24 | -78.0% | 4.1% | ||
| Q3 24 | -59.4% | 1.6% | ||
| Q2 24 | 2.3% | 0.7% |
每股收益（稀释后）AMRNINTT
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.10 | ||
| Q3 25 | $-0.02 | $-0.08 | ||
| Q2 25 | $-0.03 | $-0.04 | ||
| Q1 25 | $-0.04 | $-0.19 | ||
| Q4 24 | $-0.12 | $0.13 | ||
| Q3 24 | $-0.06 | $0.04 | ||
| Q2 24 | $0.00 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $14.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $103.6M |
| 总资产 | $645.8M | $151.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNINTT
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $14.2M | ||
| Q3 25 | $286.6M | $16.2M | ||
| Q2 25 | $298.7M | $19.2M | ||
| Q1 25 | $281.8M | $22.0M | ||
| Q4 24 | $294.2M | $19.8M | ||
| Q3 24 | $305.7M | $18.0M | ||
| Q2 24 | $306.7M | $20.4M |
总债务AMRNINTT
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $4.9M | ||
| Q2 25 | — | $5.9M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $7.9M | ||
| Q3 24 | — | $9.0M | ||
| Q2 24 | — | $10.0M |
股东权益AMRNINTT
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $103.6M | ||
| Q3 25 | $458.9M | $101.9M | ||
| Q2 25 | $464.9M | $102.6M | ||
| Q1 25 | $473.7M | $99.4M | ||
| Q4 24 | $486.2M | $99.8M | ||
| Q3 24 | $531.4M | $100.4M | ||
| Q2 24 | $551.9M | $99.5M |
总资产AMRNINTT
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $151.3M | ||
| Q3 25 | $659.8M | $148.3M | ||
| Q2 25 | $670.1M | $149.7M | ||
| Q1 25 | $655.7M | $148.0M | ||
| Q4 24 | $685.3M | $152.3M | ||
| Q3 24 | $750.6M | $158.4M | ||
| Q2 24 | $799.9M | $160.6M |
负债/权益比AMRNINTT
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.05× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.08× | ||
| Q3 24 | — | 0.09× | ||
| Q2 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-1.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-1.6M |
| 自由现金流率自由现金流/营收 | — | -4.7% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.82× |
| 过去12个月自由现金流最近4个季度 | — | $5.7M |
8季度趋势，按日历期对齐
经营现金流AMRNINTT
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $-1.0M | ||
| Q3 25 | $-12.7M | $3.5M | ||
| Q2 25 | $16.6M | $-688.0K | ||
| Q1 25 | $-12.5M | $5.5M | ||
| Q4 24 | $-13.3M | $2.6M | ||
| Q3 24 | $-2.4M | $4.2M | ||
| Q2 24 | $-2.7M | $-5.1M |
自由现金流AMRNINTT
| Q1 26 | — | — | ||
| Q4 25 | — | $-1.6M | ||
| Q3 25 | — | $3.1M | ||
| Q2 25 | — | $-1.1M | ||
| Q1 25 | — | $5.3M | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | — | $3.7M | ||
| Q2 24 | — | $-5.4M |
自由现金流率AMRNINTT
| Q1 26 | — | — | ||
| Q4 25 | — | -4.7% | ||
| Q3 25 | — | 11.8% | ||
| Q2 25 | — | -4.1% | ||
| Q1 25 | — | 19.9% | ||
| Q4 24 | — | 6.6% | ||
| Q3 24 | — | 12.4% | ||
| Q2 24 | — | -15.9% |
资本支出强度AMRNINTT
| Q1 26 | — | — | ||
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 0.9% |
现金转化率AMRNINTT
| Q1 26 | — | — | ||
| Q4 25 | — | -0.82× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.72× | ||
| Q3 24 | — | 8.58× | ||
| Q2 24 | -1.81× | -22.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
INTT
| Environmental Technologies | $8.3M | 25% |
| Semiconductor Market | $6.9M | 21% |
| Thermal Testing Products | $6.4M | 19% |
| Service And Other Products | $4.8M | 15% |
| Oem Integrators And Distributor | $3.5M | 11% |
| Semiconductor Production Test Products | $3.0M | 9% |
